due to Spectrum Pharma (SPPI) getting hammered. SPPI down appro 35% on very reduced Fusilev sales. It seems whenever one of these little biotechs getting knocked down....they all go.
Pay closer attention to why microcap biotechs trade in sympathy with others. Typically occurs among those taking similar approaches to select diseases. ONTY and SPPI are not on the same page..